Chondroitin-Akos 5% 30g ointment tube

  • $5.30
Sku: feb51ed22126
Ingredient: Chondroitin Sulfate
The instruction
for medical use


the Trade name

the International unlicensed name
Is not present

the Dosage form
Ointment for external use, 5%

of 100 g of ointment
active agent - chondroitin contains sodium sulfate
(in terms of dry matter) 5.0 g,
excipients: the dimethyl sulfoxide, lanolin anhydrous, vaseline medical, water

the Ointment of light yellow color purified the Description with a dimethyl sulfoxide smell

Pharmacotherapeutic group
Other drugs for topical treatment of diseases of the musculoskeletal system
the ATX M02AX Code

the Pharmacological

Pharmacokinetics Practically properties does not possess system absorption.
A pharmacodynamics
of Hondroitin-AKOS – the high-molecular mucopolysaccharide which is slowing down a resorption of a bone tissue and reducing calcium loss. Improves phosphorus-calcium exchange in cartilaginous tissue, accelerates processes of its restoration, slows down processes of a degeneration of cartilaginous and connective tissue. Suppresses the enzymes causing damage to cartilaginous tissue, stimulates synthesis of glikozaminoglikan, promotes regeneration of an articulate bag and the cartilaginous surfaces of joints, increases products of intra articulate liquid. In a type of the structural proximity to heparin, interferes with formation of fibrinous blood clots in a synovial and subchondral microcirculation. Reduces morbidity and the mobility of the affected joints increases.
Slows down progressing of an osteoarthrosis.
The dimethyl sulfoxide which is a part of ointment has anti-inflammatory, analgeziruyushchy and fibrinolytic effect, promotes the best penetration of chondroitin of sulfate through cellular membranes.

- an osteoarthrosis with primary damage of large joints
- intervertebral osteochondrosis

the Route of administration and doses
Hondroitin-AKOS ointment is applied by 2-3 times a day to skin over the center of defeat and rub within 2-3 minutes before full absorption. Course of treatment of 2-3 weeks. If necessary the course of treatment is repeated.
In hard cases at the same time appoint sulfate chondroitin drugs for intake or for intramuscular injections.

Side effects
are In rare instances possible allergic reactions, at the same time cancel drug.

- hypersensitivity to drug and its components
- disturbance of integrity of integuments in places of expected drawing

Medicinal interactions
is not established cases of negative medicinal interaction when prescribing ointment against the background of therapy by other medicines included in the standard schemes of treatment of degenerative diseases of joints and a backbone.

Special instructions
With care: not to use Hondroitin-AKOS ointment without consultation of the doctor at pregnancy and in the period of a lactation (breastfeeding). Teenage age up to 18 years.
It is necessary to avoid hit of ointment on mucous membranes and open wounds.
Pregnancy and the period of a lactation
At pregnancy and during breastfeeding (lactation) Hondroitin-AKOS ointment is appointed only after consultation of the doctor and care, duration of treatment is defined the doctor.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Hondroitin-AKOS Ointment does not affect ability to run vehicles and to be engaged in potentially dangerous types of activity requiring the increased concentrated attention and speed of psychomotor reactions.

The overdose
At external use of Hondroitin-AKOS ointment overdose is improbable (owing to lack of system absorption of drug). So far about cases of overdose of Hondroitin-AKOS ointment it was not reported.

A form of release and packing
On 30 g in tubas aluminum.
1 tuba with the instruction for medical use in the state and Russian languages is placed in a pack from cardboard.

To Store storage conditions in the place protected from light at a temperature from 2 °C to 20 °C.
To store out of children's reach!

3 years
not to use a period of storage after an expiration date.

Prescription status
Without prescription

JSC Sintez Producer,
Russian Federation 640008, Kurgan, Konstitutsii Avenue, 7
Ph./fax (3522) 48-16-89

the Owner of the registration certificate
of JSC Sintez, the Russian Federation

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
000100, Republic of Kazakhstan, Kostanay region, Kostanay, Uralskaya St., 14
ph. 714 228 01 79
Write a review
Related Products
Anhui Dejitang Fharmaceutical Co. Ltd (China)
Yukan Chzhuyfen 2's plaster body (analgesic)
Orling (Czech Republic)
Geladrink Forte Pineapple 30 days. doses of powder in the bank
Merckle GmbH for ratiopharm GmbH (Germany)
Diclofenac-ratiopharm 50 mg suppositories 10s
S.C. Rompharm Company S.R.L. (Romania)
Drastop 100 mg / 2 ml 10s solution for injection in ampoules
Orling (Czech Republic)
Geladrink Forte 30 days. dose capsules
Dr. Reddys (India)
Naiz 100 mg (20 tablets)
Frosst Iberica, SA (Spain)
Arcoxia ® 90 mg (28 film-coated tablets)
Out Of Stock
FitoBioTehnologii (Ukraine)
Rescue body 50 ml thermo-gel warming effect